Search

Zoran Rankovic

from Memphis, TN
Age ~60
Get Report
Related to:
Ivanka Rankovic, 56Max Smith, 45June Smith, 91Max Smith, 71Tammy Winn, 59Mariah Barringer, 33
Connected to:
Boban Rankovic, 45Milan T Rankovic, 55Sandra Rankovic, 37Henry J Rankow, 77Peter T Ranks, 48Phillip A Ranly, 40Shelby Ranly, 82Ravi L Ranmuthu, 59Donna R Rann, 63Erin A Rann, 39

Zoran Rankovic Phones & Addresses

  • 877 Harbor Isle Cir W, Memphis, TN 38103
  • Carmel, IN
  • Indianapolis, IN

Resumes

Resumes

Zoran Rankovic Photo 1

Frelance Journalist, Public Relations And Marketing

View page
Location:
Memphis, TN
Industry:
Entertainment
Work:
China Radio International (Cri)
Broadcast Journalist

Frelance Journalist, Public Relations and Marketing
Skills:
Public Relations
Microsoft Office
Microsoft Word
Powerpoint
Management
Radio Broadcasting
Microsoft Excel
Sales
Leadership
Zoran Rankovic Photo 2

Director, Cbt Chemistry Centers

View page
Location:
877 Harbor Isle Cir west #west, Memphis, TN 38103
Industry:
Pharmaceuticals
Work:
St. Jude Children's Research Hospital
Director, Cbt Chemistry Centers
Eli Lilly and Company Jun 2011 - Oct 2016
Research Fellow; Senior Group Leader
Eli Lilly and Company Jan 1, 2011 - Jun 1, 2011
Research Fellow
Merck Nov 2007 - Nov 2009
Associate Director
Organon Oct 1995 - Nov 2007
Section Head
Education:
University of Leeds Jan 1, 1993 - 1995
Doctorates, Doctor of Philosophy, Organic Chemistry University of Belgrade
Skills:
Drug Discovery
Medicinal Chemistry
Organic Chemistry
Drug Design
Drug Development
Organic Synthesis
Chemistry
Lead Change
Neuroscience
Adme
Clinical Research
Gpcrs
Therapeutic Areas
Patents
Zoran Rankovic Photo 3

Zoran Rankovic

View page

Publications

Wikipedia

Zoran Rankovi

View page

Rankovic, Zoran: Alternative names: Short description: Date of birth: 7 December 1969: Place of birth: Belgrade, SFR Yugoslavia: Date of death: Place of death

Us Patents

Tetrahydropyrrolothiazine Compounds

View page
US Patent:
20130261111, Oct 3, 2013
Filed:
Mar 27, 2013
Appl. No.:
13/851116
Inventors:
Steven James GREEN - Indianapolis IN, US
Jose Eduardo LOPEZ - Fishers IN, US
Brian Michael MATHES - Indianapolis IN, US
Dustin James MERGOTT - Zionsville IN, US
Warren Jaye PORTER - Indianapolis IN, US
Zoran RANKOVIC - Carmel IN, US
Yuan SHI - Carmel IN, US
Brian Morgan WATSON - Carmel IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 513/04
US Classification:
5142242, 544 48
Abstract:
The present invention provides compounds of Formula I:wherein A is selected from the group consisting of;Ris H or F;Ris H, —CHOH, C-C alkyl,Ris H, F, or CN;Ris H, F; or CN; andRis H, —CH, or —OCH;or a pharmaceutically acceptable salt thereof.

Substituted N-(2-(2,6-Dioxopiperidin-3-Yl)-1,3-Dioxoisoindolin-5-Yl)Arylsulfonamide Analogs As Modulators Of Cereblon Protein

View page
US Patent:
20220274948, Sep 1, 2022
Filed:
May 9, 2022
Appl. No.:
17/740148
Inventors:
- Memphis TN, US
Kevin MCGOWAN - Memphis TN, US
Jaeki MIN - Memphis TN, US
Gisele A. NISHIGUCHI - Memphis TN, US
Jeanine PRICE - Memphis TN, US
Zoran RANKOVIC - Memphis TN, US
Das SOURAV - Memphis TN, US
Charles G. MULLIGHAN - Memphis TN, US
Yunchao CHANG - Memphis TN, US
International Classification:
C07D 401/04
A61K 31/45
A61K 45/06
C07D 405/14
C07D 413/14
C07D 409/14
A61P 35/00
A61P 35/02
Abstract:
In one aspect, the disclosure relates to substituted N-(2-(2,6-dioxopiperidinyl-3-yl)-1,3-dioxoisoindolin-5-ypaiylsulfo namide analogs that useful as modulators of cereblon (CRBN) activity, methods of making same, pharmaceutical compositions comprising same, and methods of treating various clinical conditions and disorders using same, e.g., a disorder of uncontrolled cellular proliferation, such as a cancer, which may be associated with cereblon protein dysfunction and/or a GSPT1 dysfunction. In various further aspects, the disclosed compounds can selectively modulate the degradation of GSPT1 protein, i.e., the disclosed compounds can act as GSPT1 degraders. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.

Molecules And Methods Related To Treatment Of Uncontrolled Cellular Proliferation

View page
US Patent:
20220251097, Aug 11, 2022
Filed:
Jul 30, 2020
Appl. No.:
17/629268
Inventors:
- Memphis TN, US
Jamie Jarusiewicz - Memphis TN, US
Marcelo Actis - Bartlett TN, US
Yunchao Chang - Memphis TN, US
Kathryn Roberts - Memphis TN, US
Charles Mullighan - Memphis TN, US
Zoran Rankovic - Memphis TN, US
International Classification:
C07D 487/04
A61P 35/00
A61P 35/02
Abstract:
The present disclosure relates to chemical compounds that modulate cellular proliferation for the treatment of uncontrolled cellular proliferation disorders (such as cancer), pharmaceutical compositions containing such compounds, and their use in treatment. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

7-Phenylethylamino-4H-Pyrimido[4,5-D][1,3]Oxazin-2-One Compounds As Mutant Idh1 And Idh2 Inhibitors

View page
US Patent:
20210206780, Jul 8, 2021
Filed:
Mar 16, 2021
Appl. No.:
17/202867
Inventors:
- Indianapolis IN, US
Serge Louis BOULET - Fishers IN, US
Timothy Paul BURKHOLDER - Carmel IN, US
Raymond GILMOUR - Indianapolis IN, US
Patric James HAHN - Indianapolis IN, US
Zoran RANKOVIC - Memphis TN, US
International Classification:
C07D 498/04
A61P 35/02
Abstract:
A compound, as defined herein, or pharmaceutical composition containing the compound, for use in treating IDH1 or IDH2 mutant cancer and having the structure: (I).

7-Phenylethylamino-4H-Pyrimido[4,5-D][1,3]Oxazin-2-One Compounds As Mutant Idh1 And Idh2 Inhibitors

View page
US Patent:
20200079791, Mar 12, 2020
Filed:
Dec 8, 2017
Appl. No.:
16/349873
Inventors:
- Indianapolis IN, US
Serge Louis BOULET - Fishers IN, US
Timothy Paul BURKHOLDER - Carmel IN, US
Raymond GILMOUR - Indianapolis IN, US
Patric James HAHN - Indianapolis IN, US
Zoran RANKOVIC - Memphis TN, US
International Classification:
C07D 498/04
A61P 35/02
Abstract:
A compound, as defined herein, or pharmaceutical composition containing the compound, for use in treating IDH1 or IDH2 mutant cancer and having the structure: (I).

Mutant Idh1 Inhibitors

View page
US Patent:
20190292175, Sep 26, 2019
Filed:
May 30, 2017
Appl. No.:
16/302797
Inventors:
- Indianapolis IN, US
Serge Louis BOULET - Fishers IN, US
Timothy Paul BURKHOLDER - Carmel IN, US
Santiago CARBALLARES MARTIN - Madrid, ES
Raymond GILMOUR - Indianapolis IN, US
Patric James HAHN - Indianapolis IN, US
Renato Alejandro BAUER - Indianapolis IN, US
Zoran RANKOVIC - Memphis TN, US
International Classification:
C07D 413/14
A61P 35/00
Abstract:
The present application provides compounds of Formula I: Formula (I) that are useful as inhibitors of mutant IDH1, pharmaceutical compositions, and uses for the treatment of cancer.

Tetrahydropyrrolothiazine Compounds

View page
US Patent:
20140256933, Sep 11, 2014
Filed:
May 22, 2014
Appl. No.:
14/284452
Inventors:
- Indianapolis IN, US
Steven James GREEN - Indianapolis IN, US
Jose Eduardo LOPEZ - Fishers IN, US
Brian Michael MATHES - Indianapolis IN, US
Dustin James MERGOTT - Zionsville IN, US
Warren Jaye PORTER - Indianapolis IN, US
Zoran RANKOVIC - Carmel IN, US
Yuan SHI - Carmel IN, US
Brian Morgan WATSON - Carmel IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 513/04
US Classification:
544 48
Abstract:
The present invention provides compounds of Formula I:wherein A is selected from the group consisting of;Ris H or F;Ris H, —CHOH, C1-C3 alkyl,Ris H, F, or CN;Ris H, F; or CN; andRis H, —CH, or —OCH;or a pharmaceutically acceptable salt thereof.

Tetrahydropyrrolothiazine Compounds

View page
US Patent:
20140094454, Apr 3, 2014
Filed:
Dec 4, 2013
Appl. No.:
14/096443
Inventors:
- Indianapolis IN, US
Steven James GREEN - Indianapolis IN, US
Jose Eduardo LOPEZ - Fishers IN, US
Brian Michael MATHES - Indianapolis IN, US
Dustin James MERGOTT - Zionsville IN, US
Warren Jaye PORTER - Indianapolis IN, US
Zoran RANKOVIC - Carmel IN, US
Yuan SHI - Carmel IN, US
Brian Morgan WATSON - Carmel IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 513/04
US Classification:
5142242
Abstract:
The present invention provides compounds of Formula I:wherein A is selected from the group consisting of;
Control profile
Zoran Rankovic from Memphis, TN, age ~60 Get Report